(Q85660596)

English

Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion

scientific article published on 01 October 2014

Statements

Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit